235 related articles for article (PubMed ID: 36785910)
21. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ
Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
Soden SE; Saunders CJ; Willig LK; Farrow EG; Smith LD; Petrikin JE; LePichon JB; Miller NA; Thiffault I; Dinwiddie DL; Twist G; Noll A; Heese BA; Zellmer L; Atherton AM; Abdelmoity AT; Safina N; Nyp SS; Zuccarelli B; Larson IA; Modrcin A; Herd S; Creed M; Ye Z; Yuan X; Brodsky RA; Kingsmore SF
Sci Transl Med; 2014 Dec; 6(265):265ra168. PubMed ID: 25473036
[TBL] [Abstract][Full Text] [Related]
23. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
[TBL] [Abstract][Full Text] [Related]
24. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
[TBL] [Abstract][Full Text] [Related]
25. The utility of whole exome sequencing for identification of the molecular etiology in autosomal recessive developmental and epileptic encephalopathies.
Isik E; Yilmaz S; Atik T; Aktan G; Onay H; Gokben S; Ozkinay F
Neurol Sci; 2020 Dec; 41(12):3729-3739. PubMed ID: 32705489
[TBL] [Abstract][Full Text] [Related]
26. Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage.
Barbitoff YA; Polev DE; Glotov AS; Serebryakova EA; Shcherbakova IV; Kiselev AM; Kostareva AA; Glotov OS; Predeus AV
Sci Rep; 2020 Feb; 10(1):2057. PubMed ID: 32029882
[TBL] [Abstract][Full Text] [Related]
27. Clinical Utility of Next-Generation Sequencing for Developmental Disorders in the Rehabilitation Department: Experiences from a Single Chinese Center.
Liu Y; Liu X; Qin D; Zhao Y; Cao X; Deng X; Cheng Y; Liu F; Yang F; Zhang T; Yang XA
J Mol Neurosci; 2021 Apr; 71(4):845-853. PubMed ID: 32959227
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy of Whole Genome Sequencing and RNA-Seq in the Diagnosis of Whole Exome Sequencing Negative Patients with Complex Neurological Phenotypes.
Blake B; Brady LI; Rouse NA; Nagy P; Tarnopolsky MA
J Pediatr Genet; 2023 Sep; 12(3):206-212. PubMed ID: 37575640
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
Clark MM; Stark Z; Farnaes L; Tan TY; White SM; Dimmock D; Kingsmore SF
NPJ Genom Med; 2018; 3():16. PubMed ID: 30002876
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
[TBL] [Abstract][Full Text] [Related]
31. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.
Chou J; Ohsumi TK; Geha RS
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910
[TBL] [Abstract][Full Text] [Related]
32. Next-generation diagnostics: gene panel, exome, or whole genome?
Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing in intellectual disability; cost before and after a diagnosis.
Vrijenhoek T; Middelburg EM; Monroe GR; van Gassen KLI; Geenen JW; Hövels AM; Knoers NV; van Amstel HKP; Frederix GWJ
Eur J Hum Genet; 2018 Nov; 26(11):1566-1571. PubMed ID: 29959382
[TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study.
Petrovski S; Aggarwal V; Giordano JL; Stosic M; Wou K; Bier L; Spiegel E; Brennan K; Stong N; Jobanputra V; Ren Z; Zhu X; Mebane C; Nahum O; Wang Q; Kamalakaran S; Malone C; Anyane-Yeboa K; Miller R; Levy B; Goldstein DB; Wapner RJ
Lancet; 2019 Feb; 393(10173):758-767. PubMed ID: 30712878
[TBL] [Abstract][Full Text] [Related]
35. Implementation of exome sequencing in fetal diagnostics-Data and experiences from a tertiary center in Denmark.
Becher N; Andreasen L; Sandager P; Lou S; Petersen OB; Christensen R; Vogel I
Acta Obstet Gynecol Scand; 2020 Jun; 99(6):783-790. PubMed ID: 32304219
[TBL] [Abstract][Full Text] [Related]
36. The Genetic Diagnosis of Ultrarare DEEs: An Ongoing Challenge.
Musante L; Costa P; Zanus C; Faletra F; Murru FM; Bianco AM; La Bianca M; Ragusa G; Athanasakis E; d'Adamo AP; Carrozzi M; Gasparini P
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328054
[TBL] [Abstract][Full Text] [Related]
37. Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
Ramarao-Milne P; Kondrashova O; Patch AM; Nones K; Koufariotis LT; Newell F; Addala V; Lakis V; Holmes O; Leonard C; Wood S; Xu Q; Mukhopadhyay P; Naeini MM; Steinfort D; Williamson JP; Bint M; Pahoff C; Nguyen PT; Twaddell S; Arnold D; Grainge C; Basirzadeh F; Fielding D; Dalley AJ; Chittoory H; Simpson PT; Aoude LG; Bonazzi VF; Patel K; Barbour AP; Fennell DA; Robinson BW; Creaney J; Hollway G; Pearson JV; Waddell N
ESMO Open; 2022 Aug; 7(4):100540. PubMed ID: 35849877
[TBL] [Abstract][Full Text] [Related]
38. Hydrocephalus and Growth Retardation: A Fetal
Chen YS; He JF; Quan T; Li SB; Li DZ
Mol Syndromol; 2023 Jan; 13(6):522-526. PubMed ID: 36660028
[TBL] [Abstract][Full Text] [Related]
39. Analytical validation of whole exome and whole genome sequencing for clinical applications.
Linderman MD; Brandt T; Edelmann L; Jabado O; Kasai Y; Kornreich R; Mahajan M; Shah H; Kasarskis A; Schadt EE
BMC Med Genomics; 2014 Apr; 7():20. PubMed ID: 24758382
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal microarray and exome sequencing in unexplained early infantile epileptic encephalopathies in a highly consanguineous population.
Turkdogan D; Turkyilmaz A; Sager G; Ozturk G; Unver O; Say M
Int J Neurosci; 2023 Jul; 133(7):683-700. PubMed ID: 34380004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
